CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-07-08 | Lieu Hsiao VP, Clinical Research | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2010-07-08 | Evans Daron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2010-04-22 | Kazam Joshua A Chief Executive Officer | Purchase | +50,000 | 1,328,228 | ||
| 2010-04-22 | Kazam Joshua A Chief Executive Officer | Purchase · Warrant (Right to Buy) | +15,000 | 15,000 | ||
| 2010-02-15 | Lieu Hsiao VP, Clinical Research | Grant or award · Stock Option (Right to Buy) | +63,750 | 101,250 | ||
| 2010-02-15 | Evans Daron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +42,500 | 67,500 | ||
| 2010-01-19 | Lieu Hsiao VP, Clinical Research | Grant or award · Stock Option (Right to Buy) | +12,500 | 21,623 | ||
| 2010-01-19 | Evans Daron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 169,797 | ||
| 2009-09-24 | Belldegrun Arie Director | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2009-09-24 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2009-07-21 | Mieyal Paul A Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2009-07-21 | TANEN DAVID M Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2009-07-21 | SCHAFER GREGORY W Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2009-07-21 | Kazam Joshua A Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2009-07-21 | KASH PETER M Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2009-07-21 | GRANADILLO PEDRO P Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2009-07-15 | TANEN DAVID M Director | Other acquisition · Warrant (Right to Buy) | +31,650 | 31,650 | ||
| 2009-07-15 | Kazam Joshua A Director | Other acquisition · Warrant (Right to Buy) | +31,650 | 31,650 | ||
| 2009-07-15 | KASH PETER M Director | Other acquisition · Warrant (Right to Buy) | +125,000 | 125,000 | ||
| 2009-07-07 | Lieu Hsiao VP, Clinical Research | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 |
Page 27 of 31 · 605 trades